BioCorRx Inc.
Company Information
Industry
Services-Specialty Outpatient Facilities, NEC
SIC Code
8093
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
Business Address
2390 EAST ORANGEWOOD AVENUE, ANAHEIM, CA, 92806
Mailing Address
2390 EAST ORANGEWOOD AVENUE, ANAHEIM, CA, 92806
Phone
(714) 462-4880
Fiscal Year End
1231
EIN
900967447
Financial Overview
FY2025
-$11.22M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 14, 2025 | View on SEC |
| 8-K Current report of material events | August 1, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 15, 2025 | View on SEC |
Annual Reports
10-K
March 31, 2026
- Secured an $11 million NIH grant for BICX104 methamphetamine addiction research.
- Holds U.S. rights to Lucemyra, an FDA-approved opioid withdrawal treatment.
Related Companies
Companies in the same industry (SIC: 8093)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.